Angiosarcoma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Treatment, By End user, By Region and Competition, 2020-2030F

Description

The Global Angiosarcoma Treatment Market , valued at USD 280.11 Million in 2024, is projected to experience a CAGR of 6.11% to reach USD 399.85 Million by 2030. Angiosarcoma treatment encompasses a range of therapeutic strategies, including surgery, radiation therapy, chemotherapy, and targeted drug therapies, employed across various healthcare settings to manage this aggressive and rare cancer. The market's expansion is fundamentally driven by the increasing incidence of angiosarcoma cases globally, necessitating advanced therapeutic interventions.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 280.11 Million
Market Size 2030	USD 399.85 Million
CAGR 2025-2030	6.11%
Fastest Growing Segment	Immunotherapy
Largest Market	North America

Key Market Drivers

The global angiosarcoma treatment market is significantly influenced by the rising incidence of angiosarcoma cases. This aggressive rare cancer has demonstrated a notable increase in its occurrence, thereby expanding the patient population requiring therapeutic intervention. According to a study published in JAMA Network Open in April 2024, the U. S. incidence of angiosarcoma doubled from 657 newly diagnosed cases in 2001 to 1312 cases in 2019.

Key Market Challenges

A significant impediment to the expansion of the Global Angiosarcoma Treatment Market is the persistent lack of standardized treatment protocols. The inherent rarity and heterogeneous nature of angiosarcoma contribute to an absence of universally accepted clinical guidelines, resulting in considerable variability in patient care across institutions. This inconsistency directly hampers the development and adoption of advanced therapeutic interventions.

Key Market Trends

The expanding application of immunotherapy is a significant trend in the global angiosarcoma treatment market, leveraging the patient's immune system against cancer. This approach is vital for aggressive, rare cancers like angiosarcoma, where traditional therapies often have limited success. Research into tumor immunology has advanced, leading to innovative immune checkpoint inhibitors.

Key Market Players

Novartis AG
Bayer AG
Sanofi AG
Amgen Inc
Eli Lilly and Company
Genentech Inc.
Janssen Pharmaceuticals
AbbVie Inc
Bausch Health Companies Inc.
GlaxoSmithKline Plc

Report Scope:

In this report, the Global Angiosarcoma Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Angiosarcoma Treatment Market , By Type:

Hemangiosarcoma
Lymphangiosarcoma
Parenchymal Angiosarcoma

Angiosarcoma Treatment Market , By Treatment:

Surgery
Radiotherapy
Chemotherapy
Targeted Therapy
Immunotherapy
Others

Angiosarcoma Treatment Market , By End user:

Hospital & Clinics
Ambulatory Surgical Centers
Online Pharmacies

Angiosarcoma Treatment Market , By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Angiosarcoma Treatment Market .

Available Customizations:

Global Angiosarcoma Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Angiosarcoma Treatment Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Hemangiosarcoma, Lymphangiosarcoma, Parenchymal Angiosarcoma)
- 5.2.2. By Treatment (Surgery, Radiotherapy, Chemotherapy, Targeted Therapy, Immunotherapy, Others)
- 5.2.3. By End user (Hospital & Clinics, Ambulatory Surgical Centers, Online Pharmacies)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Angiosarcoma Treatment Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Treatment
- 6.2.3. By End user
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Angiosarcoma Treatment Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Treatment
    - 6.3.1.2.3. By End user
- 6.3.2. Canada Angiosarcoma Treatment Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Treatment
    - 6.3.2.2.3. By End user
- 6.3.3. Mexico Angiosarcoma Treatment Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Treatment
    - 6.3.3.2.3. By End user

7. Europe Angiosarcoma Treatment Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Treatment
- 7.2.3. By End user
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Angiosarcoma Treatment Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Treatment
    - 7.3.1.2.3. By End user
- 7.3.2. France Angiosarcoma Treatment Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Treatment
    - 7.3.2.2.3. By End user
- 7.3.3. United Kingdom Angiosarcoma Treatment Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Treatment
    - 7.3.3.2.3. By End user
- 7.3.4. Italy Angiosarcoma Treatment Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Treatment
    - 7.3.4.2.3. By End user
- 7.3.5. Spain Angiosarcoma Treatment Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Treatment
    - 7.3.5.2.3. By End user

8. Asia Pacific Angiosarcoma Treatment Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Treatment
- 8.2.3. By End user
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Angiosarcoma Treatment Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Treatment
    - 8.3.1.2.3. By End user
- 8.3.2. India Angiosarcoma Treatment Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Treatment
    - 8.3.2.2.3. By End user
- 8.3.3. Japan Angiosarcoma Treatment Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Treatment
    - 8.3.3.2.3. By End user
- 8.3.4. South Korea Angiosarcoma Treatment Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Treatment
    - 8.3.4.2.3. By End user
- 8.3.5. Australia Angiosarcoma Treatment Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Treatment
    - 8.3.5.2.3. By End user

9. Middle East & Africa Angiosarcoma Treatment Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Treatment
- 9.2.3. By End user
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Angiosarcoma Treatment Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Treatment
    - 9.3.1.2.3. By End user
- 9.3.2. UAE Angiosarcoma Treatment Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Treatment
    - 9.3.2.2.3. By End user
- 9.3.3. South Africa Angiosarcoma Treatment Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Treatment
    - 9.3.3.2.3. By End user

10. South America Angiosarcoma Treatment Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Treatment
- 10.2.3. By End user
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Angiosarcoma Treatment Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Treatment
    - 10.3.1.2.3. By End user
- 10.3.2. Colombia Angiosarcoma Treatment Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Treatment
    - 10.3.2.2.3. By End user
- 10.3.3. Argentina Angiosarcoma Treatment Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Treatment
    - 10.3.3.2.3. By End user

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Angiosarcoma Treatment Market : SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Novartis AG
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Bayer AG
15.3. Sanofi AG
15.4. Amgen Inc
15.5. Eli Lilly and Company
15.6. Genentech Inc.
15.7. Janssen Pharmaceuticals
15.8. AbbVie Inc
15.9. Bausch Health Companies Inc.
15.10. GlaxoSmithKline Plc